![](/images/png/glyphicons-368-expand.png)
![](/images/png/glyphicons-791-one-day.png)
![](/images/png/glyphicons-791-one-day.png)
![](/images/png/glyphicons-791-one-day.png)
SeraCare Life Sciences to Present at Lazard Capital Markets 7th Annual Healthcare Conference
MILFORD, Mass.--([ BUSINESS WIRE ])--SeraCare Life Sciences, Inc. (NASDAQ: SRLS) today announced that the Company will present at the Lazard Capital Markets 7th Annual Healthcare Conference on Wednesday, November 17, 2010 at 11:30 AM Eastern Time at the St. Regis, New York. Susan Vogt, President and CEO of SeraCare, will present an overview of the Companya™s business strategy, including core products and services and key initiatives that directly support SeraCarea™s global growth strategy. SeraCare serves the global life sciences industry by providing vital products and services to facilitate the discovery, validation and production of human diagnostics and therapeutics.
A live audio webcast and replay of the presentation will be available in the "Investor Relations, Events" section of the Company's website, [ www.seracare.com ].
About SeraCare Life Sciences, Inc.:
SeraCare serves the global life sciences industry by providing vital products and services to facilitate the discovery, development and production of human diagnostics and therapeutics. The Company's innovative portfolio includes diagnostic controls, plasma-derived reagents and molecular biomarkers, biobanking and contract research services. SeraCare's quality systems, scientific expertise and state-of-the-art facilities support its customers in meeting the stringent requirements of the highly regulated life sciences industry.